180 related articles for article (PubMed ID: 29351334)
1. Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes.
Chang W; Lajko M; Fawzi AA
PLoS One; 2018; 13(1):e0191285. PubMed ID: 29351334
[TBL] [Abstract][Full Text] [Related]
2. A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.
Lim JI; Spee C; Hinton DR
Retina; 2010 Oct; 30(9):1472-8. PubMed ID: 20811317
[TBL] [Abstract][Full Text] [Related]
3. APOPTOSIS AND ANGIOFIBROSIS IN DIABETIC TRACTIONAL MEMBRANES AFTER VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION: Results of a Prospective Trial. Report No. 2.
Jiao C; Eliott D; Spee C; He S; Wang K; Mullins RF; Hinton DR; Sohn EH
Retina; 2019 Feb; 39(2):265-273. PubMed ID: 29190236
[TBL] [Abstract][Full Text] [Related]
4. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.
Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F
Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
[TBL] [Abstract][Full Text] [Related]
6. Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy.
Dong Z; Kase S; Ando R; Fukuhara J; Saito W; Kanda A; Murata M; Noda K; Ishida S
Retina; 2012 Jun; 32(6):1190-6. PubMed ID: 22371118
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
[TBL] [Abstract][Full Text] [Related]
9. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.
Schwatz SD; Alexander R; Hiscott P; Gregor ZJ
Ophthalmology; 1996 Feb; 103(2):323-8. PubMed ID: 8594521
[TBL] [Abstract][Full Text] [Related]
10. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
Qian J; Lu Q; Tao Y; Jiang YR
Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.
Kim LA; Wong LL; Amarnani DS; Bigger-Allen AA; Hu Y; Marko CK; Eliott D; Shah VA; McGuone D; Stemmer-Rachamimov AO; Gai X; D'Amore PA; Arboleda-Velasquez JF
Mol Vis; 2015; 21():673-87. PubMed ID: 26120272
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glial involvement in proliferative diabetic retinopathy.
Ohira A; de Juan E
Ophthalmologica; 1990; 201(4):187-95. PubMed ID: 2077455
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes.
Ulbig MW; Wolfensberger TJ; Hiscott P; Ationu A; Carter ND; Gregor ZJ
Ger J Ophthalmol; 1995 Sep; 4(5):264-8. PubMed ID: 7496335
[TBL] [Abstract][Full Text] [Related]
16. Müller's cell involvement in proliferative diabetic retinopathy.
Nork TM; Wallow IH; Sramek SJ; Anderson G
Arch Ophthalmol; 1987 Oct; 105(10):1424-9. PubMed ID: 3117025
[TBL] [Abstract][Full Text] [Related]
17. Intraocular expression of thymosin β4 in proliferative diabetic retinopathy.
Wang JY; Lu Q; Tao Y; Jiang YR; Jonas JB
Acta Ophthalmol; 2011 Aug; 89(5):e396-403. PubMed ID: 21332672
[TBL] [Abstract][Full Text] [Related]
18. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
19. Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy.
Kase S; Saito W; Ohgami K; Yoshida K; Furudate N; Saito A; Yokoi M; Kase M; Ohno S
Br J Ophthalmol; 2007 Oct; 91(10):1376-8. PubMed ID: 17522145
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes.
Schneeberger SA; Hjelmeland LM; Tucker RP; Morse LS
Am J Ophthalmol; 1997 Oct; 124(4):447-54. PubMed ID: 9323936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
